fbpx
March 16, 2021

Nephron Sterile Compounding Center LLC – 610867 – 02/19/2021

Reference #: ANDA 78202 Product: Drugs Recipient: Recipient Name Lou Kennedy Recipient Title CEO and Owner Nephron Sterile Compounding Center LLC 4500 12th Street ExtensionWest Columbia, […]
March 16, 2021

Albek de Mexico S.A. de C.V. – 609202 – 03/11/2021

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. José Manuel Beltrán Mendoza Recipient Title CEO/President Albek de Mexico S.A. de C.V. Oriente 4 No. […]
March 16, 2021

Foshan Biours Biosciences Co., Ltd. – 611319 – 03/10/2021

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Paul Huang Recipient Title General Manager/CEO Foshan Biours Biosciences Co., Ltd. 13 East Xile Road, Tower […]
March 16, 2021

Dibar Nutricional S. de R.L. de C.V. – 610444 – 03/10/2021

Delivery Method: VIA UPS Reference #: 320-21-33 Product: Drugs Recipient: Recipient Name Mr. José Antonio Díaz Barriga Ahued Recipient Title President & CEO Dibar Nutricional S. […]
March 16, 2021

Nephron SC Inc. – 610867 – 09/22/2020

Product: Drugs Recipient: Recipient Name Lou Kennedy Recipient Title CEO and Owner Nephron SC Inc. 4500 12th Street ExtensionWest Columbia, SC 29172United States Issuing Office: Office […]
March 16, 2021

Morphine Milligram Equivalents: Current Applications and Knowledge Gaps, Research Opportunities, and Future Directions; Public Workshop; Request for Comments – 07/08/2021 – 07/09/2021

On This Page Date: July 8 – 9, 2021 Time: 9:00 AM – 5:00 PM ET DESCRIPTION/SUMMARY This public workshop is currently being scheduled and planned […]
March 15, 2021

Potential Medication Error Risks With Investigational Drug Container Labels Public Meeting May 18-19, 2021 – 05/18/2021 – 05/19/2021

On This Page Date: May 18 – 19, 2021 Time: 1:00 PM – 1:00 PM ET Times: May 18: 1 – 4pm | May 19: 10am […]
March 15, 2021

Labeling Made Simple: The How, What, and Where of Drug Interactions in Prescribing Information

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs […]
March 15, 2021

Office of New Drugs (OND) | Annual Reports

2020 marked the first year the Office of New Drugs (OND) developed an Annual Report. This report offers readers insight into OND’s priorities through a message […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0